caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1235117821

Cynthia SloanD.O.

PRACTICEMAMAD BAGHERI MD PASee all providers at this practice →
NeurologyWichita Falls, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 450010
Hospital
REFERRAL NETWORK

Where Cynthia Sloan's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 7 outbound destinations.

Receives referrals from
Inbound — who sends patients here
No inbound pairs above the suppression threshold.
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
CHCA CONROE LP2345
Laboratory Corporation Of America
Clinical Laboratory · Houston, TX
2145
MEMORIAL HERMANN HEALTH SYSTEM1648
Clinical Pathology Laboratories, Inc.
Clinical Laboratory · Austin, TX
1337
WOODLANDS OPEN MRI & IMAGING CENTER L P1221
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Houston, TX
1239
MEMORIAL HERMANN HEALTH SYSTEM1131
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
791
Unique beneficiaries
—
Total services
1,042
Distinct HCPCS
8
Medicare payment
$98K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,109 Neurology providers in TX — above median (cohort median 629).
PRESCRIBING · PART D · 2024
Total Rx claims
3,026
Beneficiaries
—
Total drug cost
$526K
Distinct drugs
51
Brand share
17.6%
Top prescribed drugs
Donepezil Hcl375 claims
Gabapentin219 claims
Levetiracetam193 claims
Topiramate189 claims
Memantine Hcl183 claims
QUALITY · MIPS · 2024
Final MIPS score
77.4
Quality
67.0
Cost
57.7
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.10%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$5K
Payment records
34
By payment type
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$4K
Food and Beverage$1K
Travel and Lodging$489